Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxeltis
Montpellier, Occitanie, Franceoxeltis.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Oxeltis provides medicinal chemistry services including hit-to-lead optimization, custom synthesis of complex organic molecules, and route scouting. The company has completed over 35 projects with several client drug candidates advancing to clinical development. It specializes in challenging chemistries such as heterocycles, macrocycles, nucleos(t)ides, phosphoramidites, modified sugars/oligosaccharides and PROTAC-related syntheses. Clients include major global pharmaceutical companies as well as biotechs across Europe, North America and Japan.
- Therapeutic areas
- OncologyNeurologyInfectious Diseases
- Modalities
- Small moleculePeptidesOligosaccharidesPROTACs (Proteolysis-targeting chimeras)Nucleosides/nucleotides (nucleos(t)ides)Phosphoramidites
- Industry
- Drug Discovery Services
02
Partnerships
Molecular Forecaster Inc. – strategic partnership integrating computational design with chemical synthesis for early-stage drug discovery support.Works with five of the top ten global pharma companies on contract basis.
Beyond the preview
Go deeper on Oxeltis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxeltis.